And if larger clinical trials demonstrate the effectiveness of mRNA vaccines in preventing recurrences, will some patients with cancer still refuse them because of widespread misinformation about the technology? My latest for @jama.com:

Excited to be interviewed for JAMA Medical News about the promise of mRNA cancer vaccines and how misinformation may limit their impact. A reminder that scientific innovation and effective communication must go hand in hand.

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it, writes Dannell D. Boatman. theconversation.com/cancer-vacci...

Had a great time presenting at WVU Cancer Institute Oncology Grand Rounds yesterday on clinical trial communication. To improve participation and equity, communication has to be treated as part of the clinical trial itself not just an afterthought. #clinicaltrials #healthcommunication

Vaccines offer an exciting opportunity for the future of cancer care. Misinformation could hold that future back. I wrote about what this could mean for trust and communication in @theconversation.com ⬇️

I was recently interviewed by USA TODAY about my research on #HPV vaccination #misinformation on social media. I’m very glad this topic is getting some attention as the impact of misinformation and #disinformation on social media continues to be a real challenge to #publichealth. t.co/LJPhZOJKJV